Approximately 40-60% of people with multiple sclerosis (MS) have memory problems, which adversely impact on their everyday functioning. Evidence supports the use of external memory aids in people with stroke and brain injury, and suggests they may reduce everyday memory problems in people with MS. Previous reviews of people with MS have only evaluated randomised trials; therefore this review included other methodologies. The aim was to assess the efficacy of external memory aids for people with MS for improving memory functioning, mood, quality of life, and coping strategies. Seven databases were systematically searched. Intervention studies that involved training in the use of external memory aids, e.g., personal digital assistants, with a...
© 2014 MA Healthcare Ltd. Background/Aim: Memory problems are frequently reported in people with mul...
In this explorative study, forty-seven patients with relapsing-remitting multiple sclerosis were ran...
While previous randomised controlled trials and meta-analyses offer only limited evidence for the ef...
Memory problems are reported in 40-60% of people with multiple sclerosis (MS). These problems affect...
Background Problems with cognition, particularly memory, are common in people with multiple scleros...
Objective: To determine the quantity and quality of description of cognitive rehabilitation for cogn...
Abstract Background Cognitive impairment is a common clinical feature of multiple sclerosis (MS)...
BackgroundPeople with multiple sclerosis have problems with memory and attention. Cognitive rehabili...
People with multiple sclerosis frequently report cognitive problems, which can affect function and q...
Introduction: Up to 70% of people with multiple sclerosis (MS) experience mild to moderate cognitive...
Memory problems are reported in 40%-60% of people with multiple sclerosis (MS). These problems affec...
Background People with multiple sclerosis have problems with memory and attention. Cognitive rehabi...
Objective: To assess the clinical and cost-effectiveness of cognitive rehabilitation for attention a...
Objective: To assess the feasibility and effectiveness of a group memory rehabilitation programme co...
Background: People with multiple sclerosis have problems with memory and attention. Cognitive rehabi...
© 2014 MA Healthcare Ltd. Background/Aim: Memory problems are frequently reported in people with mul...
In this explorative study, forty-seven patients with relapsing-remitting multiple sclerosis were ran...
While previous randomised controlled trials and meta-analyses offer only limited evidence for the ef...
Memory problems are reported in 40-60% of people with multiple sclerosis (MS). These problems affect...
Background Problems with cognition, particularly memory, are common in people with multiple scleros...
Objective: To determine the quantity and quality of description of cognitive rehabilitation for cogn...
Abstract Background Cognitive impairment is a common clinical feature of multiple sclerosis (MS)...
BackgroundPeople with multiple sclerosis have problems with memory and attention. Cognitive rehabili...
People with multiple sclerosis frequently report cognitive problems, which can affect function and q...
Introduction: Up to 70% of people with multiple sclerosis (MS) experience mild to moderate cognitive...
Memory problems are reported in 40%-60% of people with multiple sclerosis (MS). These problems affec...
Background People with multiple sclerosis have problems with memory and attention. Cognitive rehabi...
Objective: To assess the clinical and cost-effectiveness of cognitive rehabilitation for attention a...
Objective: To assess the feasibility and effectiveness of a group memory rehabilitation programme co...
Background: People with multiple sclerosis have problems with memory and attention. Cognitive rehabi...
© 2014 MA Healthcare Ltd. Background/Aim: Memory problems are frequently reported in people with mul...
In this explorative study, forty-seven patients with relapsing-remitting multiple sclerosis were ran...
While previous randomised controlled trials and meta-analyses offer only limited evidence for the ef...